• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

CD81and other molecules as regulator of complement activation.

Prescribing for the elderly is normally challenging due to the paucity

February 11, 2019 by Katherine Lewis Leave a Comment

Prescribing for the elderly is normally challenging due to the paucity of clinical trial proof therapeutic benefit within this population and the current presence of evidence that the elderly are at elevated threat of adverse medicine reactions. The clearance of medicines by the liver organ depends upon hepatic blood circulation and intrinsic clearance (enzyme activity … [Read more…]

Posted in: Blogging Tagged: AZD6244, CD81and other molecules as regulator of complement activation., Mouse monoclonal to CD21.transduction complex containing CD19

Obesity is associated with a number of disorders and it is

June 2, 2017 by Katherine Lewis Leave a Comment

Obesity is associated with a number of disorders and it is a significant medical condition in developed countries. research utilized mice lacking in cyclooxygenase-2 (COX-2) to examine the role of COX-2-derived HMN-214 PGs as modulators of adiposity. As compared with strain- and age-matched wild-type controls the genetic deficiency of COX-2 resulted in a significant reduction … [Read more…]

Posted in: DUB Tagged: CD81and other molecules as regulator of complement activation., HMN-214, Mouse monoclonal to CD21.transduction complex containing CD19

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by